Combined hepatitis B vaccines

被引：12

作者：

FitzSimons, D

François, G

Emiroglu, N

Van Damme, P

机构：

[1] Univ Instelling Antwerp, Dept Epidemiol & Social Med, WHO Collaborating Ctr, Viral Hepatitis Prevent Board, B-2610 Antwerp, Belgium

[2] WHO, CH-1211 Geneva, Switzerland

[3] WHO, Reg Off Europe, Vaccine Preventable Dis & Immunisat Programme, DK-2100 Copenhagen, Denmark

来源：

VACCINE | 2003年 / 21卷 / 13-14期

关键词：

D O I：

10.1016/S0264-410X(02)00636-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed. Data on the safety, immunogenicity, and European licensing status and availability of haxavalent vaccines combining hepatitis B (HepB), Haemophilus influenza type b (Hib), diphtheria, tetanus, and pertussis (acellular) (DTPa), and inactivated poliovirus (IPV) antigens were presented. Finally, the impact of the availability of combined hepatitis B vaccines on hepatitis B immunisation programmes in Europe were examined and the added value of combined hepatitis B vaccines globally was estimated. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：1310 / 1316

页数：7

共 8 条

[1] Angelillo IF, 1999, B WORLD HEALTH ORGAN, V77, P224
[2] Factors influencing vaccine uptake in Italy
Bonanni, P
Bergamini, M
[J]. VACCINE, 2001, 20 : S8 - S12
[3] Principles of pediatric combination vaccines and practical issues related to use in clinical practice
Decker, MD
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (11) : S10 - S18
[4] Considerations for hepatitis B as part of a combination vaccine
Greenberg, DP
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (11) : S34 - S39
[5] The hidden costs of infant vaccination
Lieu, TA
Black, SB
Ray, GT
Martin, KE
Shinefield, HR
Weniger, BG
[J]. VACCINE, 2000, 19 (01) : 33 - 41
[6] Factors influencing vaccine uptake in Germany
Schmitt, HJ
[J]. VACCINE, 2001, 20 : S2 - S4
[7] Analysis of factors influencing vaccine uptake: perspectives from Belgium
Swennen, B
Van Damme, P
Vellinga, A
Coppieters, Y
Depoorter, AM
[J]. VACCINE, 2001, 20 : S5 - S7
[8] Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium
Vellinga, A
Depoorter, AM
Van Damme, P
[J]. ACTA PAEDIATRICA, 2002, 91 (05) : 599 - 603

← 1 →